Clinical Trials

Font Resizer

Dr. Tyson, is dedicated to providing the highest quality of patient care and the research department is an integral part of our practice. As a participant in clinical research, our practice is approached by pharmaceutical and device companies specializing in ophthalmology to conduct clinical studies. We are committed to conducting clinical studies that evaluate new medications and surgical innovations (procedures and devices.) It’s exciting to work in conjunction with other researchers in the quest to find the safest and most effective medications and treatments to preserve and restore vision due to ocular diseases and conditions.

Patient Safety:

To ensure the rights and safety of our research patients, the clinical studies are overseen by the Food and Drug Administration and national Independent Review Boards. Clinical research offers great opportunity to patients, but just like with any medication or surgery there is some degree of risk. The physicians and staff at Eye Associates always put the safety and welfare of our patients first when deciding participation in FDA supported clinical studies.

Our Philosophy:

Patients’ happiness, overall satisfaction, and health interests are vitally important to us. Your participation in a clinical trial may or may not benefit you directly, but your involvement helps advance ophthalmology care for the general population in the future.

The commitment of our physicians and staff allows our practice to provide and maintain the highest quality of care for each of our valued patients. If you are interested in learning more, feel free to ask us for information on our current clinical trials.

Sponsor / Study

Title:
TRANSCEND MEDICAL, INC.

An extension of the original study TMI-09-01. A PROSPECTIVE, RANDOMIZED, COMPARATIVE, MULTICENTER CLINICAL STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF THE TRANSCEND CYPASS GLAUCOMA IMPLANT IN PATIENTS WITH OPEN ANGLE GLAUCOMA UNDERGOING CATARACT SURGERY (THE COMPASS TRIAL)
Protocol Number: TMI-09-01-E
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study

Title:
Ocular Therapeutix, Inc.
DEXTENZA CLINICAL STUDY. A PROSPECTIVE, MULTICENTER, RAMDOMIZED, PARALLEL-ARM, DOUBLE-MASKED, VEHICLE CONTROLLED PHASE 3 STUDY EVALUATING THE SAFETY AND EFFICACY OF DEXTEZA FOR TREATMENT OF OCULAR INFLAMMATION AND PAIN AFTER CATARACT SURGERY.
Protocol Number: OTX-15-003
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study

Title:
GLAUKOS CORPORATION,

A PROSPECTIVE, RANDOMIZED, SINGLE-MASKED, CONTROLLED, PARALLEL GROUPS, MULTI CENTER CLINICAL INVESTIGATION OF A GLAUKOS TRABECULAR MICRO-BYPASS STENT SYSTEM IN CONJUNCTION WITH CATARACT SURGERY.
Protocol Number: GC-008
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study

Title:
WAVETEC VISION SYSTEMS, INC.

A MULTI-CENTER, PROSPECTIVE, EVALUATION OF REAL-TIME IMAGES CAPTURED ON APHAKIC EYES UTILIZING THE OPTIWAVE™ REFRACTIVE ANALYSIS ABERROMETER (ORA SYSTEM™).
Protocol Number: WA-12-001 (ALPHA)
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study

Title:
TRANSCEND MEDICAL, INC.

A PROSPECTIVE, RANDOMIZED, COMPARATIVE, MULTICENTER CLINICAL STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF THE TRANSCEND CYPASS GLAUCOMA IMPLANT IN PATIENTS WITH OPEN ANGLE GLAUCOMA UNDERGOING CATARACT SURGERY (THE COMPASS TRIAL)
Protocol Number: TMI-09-01
Principal Investigator: Sydney Tyson, MD, MPH
Sponsor / Study

Title:
ALCON RESEARCH
A COMPARATIVE STUDY OF OLOPATADINE 0.2% VERSUS VEHICLE IN PATIENTS WITH SEASONAL ALLERGIC CONJUNCTIVITIS OR RHINOCONJUNCTIVITIS
Protocol Number: C-04-60
Principal Investigator: Sydney Tyson, MD, MPH
Sponsor / Study

Title:
ABBOTT MEDICAL OPTICS, INC.
Tecnis Multifocal 1-Piece IOL Evaluation Registry
Protocol Number: Post-market Observational Study Only, US
Principal Investigator: Sydney Tyson, MD, MPH
Ask A Question
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form